Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
0.700 GeneticVariation disease UNIPROT Periventricular Calcification, Abnormal Pterins and Dry Thickened Skin: Expanding the Clinical Spectrum of RMND1? 26238252 2016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
0.700 Biomarker disease GENOMICS_ENGLAND Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. 27604308 2016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
0.700 GeneticVariation disease UNIPROT RMND1 deficiency associated with neonatal lactic acidosis, infantile onset renal failure, deafness, and multiorgan involvement. 25604853 2015
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
0.700 Biomarker disease GENOMICS_ENGLAND Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. 25058219 2014
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
0.700 GeneticVariation disease UNIPROT Infantile encephaloneuromyopathy and defective mitochondrial translation are due to a homozygous RMND1 mutation. 23022099 2012
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
0.700 Biomarker disease GENOMICS_ENGLAND Infantile encephaloneuromyopathy and defective mitochondrial translation are due to a homozygous RMND1 mutation. 23022099 2012
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
0.700 GermlineCausalMutation disease ORPHANET An RMND1 Mutation causes encephalopathy associated with multiple oxidative phosphorylation complex deficiencies and a mitochondrial translation defect. 23022098 2012
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
0.700 GermlineCausalMutation disease ORPHANET Infantile encephaloneuromyopathy and defective mitochondrial translation are due to a homozygous RMND1 mutation. 23022099 2012
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
0.700 GeneticVariation disease UNIPROT An RMND1 Mutation causes encephalopathy associated with multiple oxidative phosphorylation complex deficiencies and a mitochondrial translation defect. 23022098 2012
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
0.700 CausalMutation disease CLINVAR
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
0.700 Biomarker disease CTD_human
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.310 Biomarker disease CTD_human A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. 29915430 2018
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.310 Biomarker disease CTD_human A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. 29915430 2018
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.310 GeneticVariation disease BEFREE We examined the association of rs2046210 and its six linkage disequilibrium SNPs with clinicopathological characteristics, prognosis, and gene expression levels of ESR1 and the C6ORFs (C6ORF97:CCDC170, C6ORF211, C6ORF96:RMND1) in 344 breast cancer tissue samples and 253 corresponding samples of adjacent normal tissue. 25370037 2015
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.310 GeneticVariation disease BEFREE We examined the association of rs2046210 and its six linkage disequilibrium SNPs with clinicopathological characteristics, prognosis, and gene expression levels of ESR1 and the C6ORFs (C6ORF97:CCDC170, C6ORF211, C6ORF96:RMND1) in 344 breast cancer tissue samples and 253 corresponding samples of adjacent normal tissue. 25370037 2015
CUI: C1257931
Disease: Mammary Neoplasms, Human
Mammary Neoplasms, Human
0.300 Biomarker disease CTD_human A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. 29915430 2018
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.300 Biomarker group CTD_human A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. 29915430 2018
CUI: C4704874
Disease: Mammary Carcinoma, Human
Mammary Carcinoma, Human
0.300 Biomarker disease CTD_human A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. 29915430 2018
CUI: C0001125
Disease: Acidosis, Lactic
Acidosis, Lactic
0.120 GeneticVariation phenotype BEFREE Careful clinical phenotyping, including for lactic acidosis, deafness, and severe muscle involvement seen in RMND1 mutation positive individuals, and MRI pattern recognition will be important in differentiating these patients from children with congenital infections like cytomegalovirus. 27843092 2017
CUI: C0001125
Disease: Acidosis, Lactic
Acidosis, Lactic
0.120 Biomarker phenotype BEFREE RMND1 deficiency associated with neonatal lactic acidosis, infantile onset renal failure, deafness, and multiorgan involvement. 25604853 2015
CUI: C0001125
Disease: Acidosis, Lactic
Acidosis, Lactic
0.120 Biomarker phenotype HPO
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.110 Biomarker group BEFREE Characterization of the renal phenotype in RMND1-related mitochondrial disease. 31568715 2019
CUI: C0036572
Disease: Seizures
Seizures
0.110 GeneticVariation phenotype BEFREE Recently, two research groups reported that mutations in RMND1 were associated with encephalopathy, elevated lactate, hypotonia, and in some patients seizures or myoclonia in individuals from two consanguineous families. 26395190 2016
CUI: C0751651
Disease: Mitochondrial Diseases
Mitochondrial Diseases
0.110 CausalMutation group CLINVAR The clinical, biochemical and genetic features associated with RMND1-related mitochondrial disease. 27412952 2016
CUI: C1384666
Disease: hearing impairment
hearing impairment
0.110 GeneticVariation phenotype BEFREE Hearing impairment and renal failure associated with RMND1 mutations. 26395190 2016